Potential motivators affecting parental intention in COVID-19 vaccination for children aged 6 months to 4 years: Implications for targeted vaccine interventions in Japan

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2023-12-19 DOI:10.1080/21645515.2023.2296737

Yukiko Kato, Tomohiro Shinozaki, Daisuke Sugiyama, Atsuko Taguchi, Satoko Nagata

引用次数: 0

Abstract

Although COVID-19 vaccination was approved for younger children in Japan in October 2022, uptake rates remain critically low. This study aimed to investigate Japanese parents’ intentions, hesitator...

查看原文本刊更多论文

影响家长为 6 个月至 4 岁儿童接种 COVID-19 疫苗意向的潜在动机：对日本有针对性的疫苗干预措施的影响

尽管 COVID-19 疫苗接种已于 2022 年 10 月在日本获得批准，但接种率仍然很低。本研究旨在调查日本家长接种COVID-19疫苗的意向、犹豫不决的态度以及对接种COVID-19疫苗的兴趣。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.